High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.

Fifty-one lepromatous leprosy patients, all of whom had relapsed after previous dapsone (DDS) monotherapy, were treated between 1990 and 1991 with 600 mg of rifampin (RMP) plus 400 mg of ofloxacin (OFLO) daily for 4 weeks, and the great majority of the patients were followed up at least once a year...

Full description

Saved in:
Bibliographic Details
Main Authors: Ji, B, Jamet, P, Sow, S, Perani, E G, Traore, I, Grosset, J H
Format: Artigo
Language:Inglês
Published: 1997
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC164043/
https://ncbi.nlm.nih.gov/pubmed/9303392
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items